|
1
|
Bae JM, Won YJ, Jung KW and Park JG:
Annual report of the Korean central cancer registry program 2000.
Cancer Res Treat. 34:77–83. 2002.
|
|
2
|
Douillard JY, Cunningham D, Roth AD, et
al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: a multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar
|
|
3
|
Saltz LB, Cox JV, Blanke C, et al:
Irinotecan plus fluorouracil and leucovorin for metastatic
colorectal cancer. Irinotecan Study Group. N Engl J Med.
343:905–914. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Gramont A, Figer A, Seymour M, et al:
Leucovorin and fluorouracil with or without oxaliplatin as
first-line treatment in advanced colorectal cancer. J Clin Oncol.
18:2938–2947. 2000.
|
|
5
|
Jeung HC, Rha SY, Cho BC, et al: A phase
II trial of S-1 monotherapy in metastatic colorectal cancer after
failure of irinotecan- and oxaliplatin-containing regimens. Br J
Cancer. 95:1637–1641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chester JD, Dent JT, Wilson G, Ride E and
Seymour MT: Protracted infusional 5-fluorouracil (5-FU) with bolus
mitomycin in 5-FU-resistant colorectal cancer. Ann Oncol.
11:235–237. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seitz JF, Perrier H, Giovannini M,
Capodano G, Bernardini D and Bardou VJ: 5-Fluorouracil, high-dose
folinic acid and mitomycin C combination chemotherapy in previously
treated patients with advanced colorectal carcinoma. J Chemother.
10:258–265. 1998. View Article : Google Scholar
|
|
8
|
Russello O, Romanini A, Civalleri D, Rosso
R, Nicolin A and Sobrero A: Time-dependent interactions between
5-fluorouracil and mitomycin C on a human colon carcinoma cell
line, HCT-8, in vitro. Eur J Cancer Clin Oncol. 25:571–572.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross P, Norman A, Cunningham D, et al: A
prospective randomized trial of protracted venous infusion
5-fluorouracil with or without motomycin C in advanced colorectal
cancer. Ann Oncol. 8:995–1001. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tebbutt NC, Norman A, Cunningham D, et al:
A multicentre, randomized phase III trial comparing protracted
venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus
mitomycin C in patients with inoperable oesophago-gastric cancer.
Ann Oncol. 13:1568–1575. 2002. View Article : Google Scholar
|
|
11
|
Hurwitz H, Fehrenbacher L, Novotny W, et
al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for
metastatic colorectal cancer. N Engl J Med. 350:2335–2342. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karapetis CS, Khambata-Ford S, Jonker DJ,
et al: K-ras mutations and benefit from cetuximab in advanced
colorectal cancer. N Engl J Med. 359:1757–1765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim DH, Park YS, Park BB, et al:
Mitomycin-C and capecitabine as third-line chemotherapy in patients
with advanced colorectal cancer: a phase II study. Cancer Chemother
Pharmacol. 56:10–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cunningham D, Humblet Y, Siena S, et al:
Cetuximab monotherapy and cetuximab plus irinotecan in
irinotecan-refractory metastatic colorectal cancer. N Engl J Med.
351:337–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuyama S, Inada T, Oyama R and Ogata Y:
Phase II study of mitomycin C, cisplatin and 5-fluorouracil for
advanced and recurrent gastric cancer. Anticancer Res.
22:3633–3636. 2002.PubMed/NCBI
|
|
16
|
Kornek GV, Schuell B, Laengle F, et al:
Mitomycin C in combination with capecitabine or biweekly high-dose
gemcitabine in patients with advanced biliary tract cancer: a
randomised phase II trial. Ann Oncol. 15:478–483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SH, Kim YS, Hong J, et al: Mitomycin
C plus S-1 as second-line therapy in patients with advanced gastric
cancer: a noncomparative phase II study. Anticancer Drugs.
19:303–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
